Personal neoantigen cancer vaccines: The momentum builds

DSpace/Manakin Repository

Personal neoantigen cancer vaccines: The momentum builds

Citable link to this page

 

 
Title: Personal neoantigen cancer vaccines: The momentum builds
Author: Fritsch, Edward F; Hacohen, Nir; Wu, Catherine J

Note: Order does not necessarily reflect citation order of authors.

Citation: Fritsch, Edward F, Nir Hacohen, and Catherine J Wu. 2014. “Personal neoantigen cancer vaccines: The momentum builds.” Oncoimmunology 3 (1): e29311. doi:10.4161/onci.29311. http://dx.doi.org/10.4161/onci.29311.
Full Text & Related Files:
Abstract: Neoantigen-based cancer vaccines designed to target the unique immunogenic mutations arising in each patient’s tumor are breathing new life into a struggling approach. Data continue to demonstrate the importance of neoantigens in immune control of cancer. Despite manufacturing complexity, outstanding questions and desired further improvements, neoantigen vaccines are currently undergoing clinical evaluation.
Published Version: doi:10.4161/onci.29311
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121338/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:12785970
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters